Regarding genetics, among the 3 common lung cancer gene variants (EGFR mutation, KRAS mutation, and EML4/ALK rearrangement), EML4/ALK rearrangement is considered to be a high-risk factor for the development of PE [20]. This evidence concerns the gene EML4 and lung cancer.